Professional Documents
Culture Documents
www.cancerjournal.net
Original Article
INTRODUCTION
Radiation myelitis refers exclusively to the syndrome
of chronic progressive radiation myelopathy, as
defined by Reagan et al.[1] This syndrome usually
begins about 9 to 15 months (according to some
authors up to 3 years) after the end of irradiation
with paresthesias, other sensory disturbances and
some-times with later development of bowel and
bladder dysfunction.[2] Four clinical syndromes of
radiation myelopathy, which have been traditionally
described, are acute transient radiation myelopathy,
acutely developing paraplegia or quadriplegia,
lower motor neuron disease in the upper or lower
extremities and chronic progressive radiation
myelopathy.[1]
Radiation damage to the spinal cord is one of the
most dreaded complication in the clinical practice of
radiotherapy. Radiation oncologists, consequently
are always concerned about the dose to the spinal
cord. Factors which have been implicated in radiation
tolerance of the cord are total dose, dose per fraction,
length (volume) of the spinal cord, irradiated
segment of spinal cord and reirradiation of the
cord.[3,4] Unfortunately, we did not find any mention
J Cancer Res Ther - June 2006 - Volume 2 - Issue 2
Munshi Anusheel,
Ramachandran
Prabhakar,
Department of
Radiation Oncology
All India Institute of
Medical Sciences, New
Delhi, India
For correspondence:
Munshi Anusheel,
Department of
Radiation Oncology,
Medical Sciences,
E-mail:
anusheel8@hotmail.com
Diagnosis
Carcinoma pyriform sinus
Carcinoma base of tongue
Carcinoma post cricoid
Carcinoma larynx
Carcinoma vallecula
Carcinoma BOT
Carcinoma larynx
Carcinoma tonsil
Stage
T3N0M0
T3N2CM0
T3N1M0
T2N1M0
T2N0M0
T3N1M0
T3N0M0
T2N2cM0
66
Field size
A-P (X x Y)
20 x 14
10 x 18
17 x 15
19 x 14
18 x 16
21 x 18
20 x 16
19 x 19
B/L (X x Y)
11 x 14
19 x 18
12 x 15
11 x 14
11 x 16
12 x 18
12 x 16
21 x 19
Table 3: DVH analysis of the spinal cord (with a fraction size of 200 cGy)
Patient no.
1
1
2
2
3
3
4
4
5
5
6
6
7
7
8
8
A-P
B/L
A-P
B/L
A-P
B/L
A-P
B/L
A-P
B/L
A-P
B/L
A-P
B/L
A-P
B/L
Minimum
9.2
4.3
6.7
4.4
9.6
3.7
4.1
2.6
18.5
7.9
6
4
13.1
4.1
14.9
7.9
Maximum
241.4
203
208.4
204.6
215.4
201.6
221.3
193.9
202.5
199.2
202
175
230
184.4
206.5
199.2
Mean
202.5
154
159.8
144
150.9
112.5
148.5
127.7
171.1
139
150
130
189.7
123.8
172
139
Median
221.8
196.2
182.8
193.5
199.6
124.8
198.5
178.2
183.7
170.8
182
160
202.5
168.9
193.5
170
SD
62.4
67.6
66.32
73.27
77.81
74.89
84.2
78.89
39.2
59.4
70
82
50.71
72.9
52.23
59.14
2.
3.
4.
5.
Based on our study, we feel a lower dose limit for spine shielding
should be considered for the A-P technique. The cut off dose
can be decided after studying a larger set of patients and the
DVHs of the cord, with more anatomical variations. In our
limited study, we found that a 20% excess in mean dose and a
10% increase in maximum dose, was received by the cord in A
P technique. We propose, that in case of open field technique,
we should spare the cord at least 4.5 to 9 Gy, before the dose
limit we choose for the bilateral field technique. While drawing
inferences from our study, it is important to note that tissue
compensators were not used in the study for patients, for either
field arrangement. We emphasise that this variation in the
dose to the spinal cord will be highly diminished, if
Modal
212.2
199.9
207.8
189.5
208
192.4
209.3
2.8
195.7
194
179
140
200.6
110.3
200.5
194
6.
7.
8.
9.
67